Literature DB >> 3566253

Peritoneal transport of cefonicid.

G D Morse, T Lane, D K Nairn, J Deterding, J Curry, P Gal.   

Abstract

The pharmacokinetic characteristics of cefonicid, a highly protein-bound expanded-spectrum cephalosporin, were examined in six noninfected, clinically stable patients undergoing continuous ambulatory peritoneal dialysis. After a 1.0-g intravenous dose of cefonicid, the mean concentrations in serum were 105 +/- 25 and 35.6 +/- 14.4 micrograms/ml at 3 and 72 h, respectively. Despite a prolonged half-life in serum of 49.7 +/- 18 h, the penetration into peritoneal fluid was low. The average concentration in dialysate over the 72-h study period was 2.7 micrograms/ml. The serum clearance was 2.6 +/- 1.0 ml/min, and the distribution volume was 0.14 +/- 0.02 liter/kg. Dosage recommendations and clinical considerations for cefonicid use in continuous ambulatory peritoneal dialysis patients are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3566253      PMCID: PMC174708          DOI: 10.1128/AAC.31.2.292

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

Review 1.  Microbiologic aspects of chronic ambulatory peritoneal dialysis.

Authors:  S I Vas
Journal:  Kidney Int       Date:  1983-01       Impact factor: 10.612

2.  LAGRAN program for area and moments in pharmacokinetic analysis.

Authors:  M L Rocci; W J Jusko
Journal:  Comput Programs Biomed       Date:  1983-06

3.  Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.

Authors:  S L Barriere; G J Hatheway; J G Gambertoglio; E T Lin; J E Conte
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

Review 4.  Central venous catheter-induced endocarditis: human correlate of the animal experimental model of endocarditis.

Authors:  M M Tsao; D Katz
Journal:  Rev Infect Dis       Date:  1984 Nov-Dec

5.  Peritoneal clearances.

Authors:  K D Nolph
Journal:  J Lab Clin Med       Date:  1979-10

6.  SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels.

Authors:  P Actor; J V Uri; I Zajac; J R Guarini; L Phillips; D H Pitkin; D A Berges; G L Dunn; J R Hoover; J A Weisbach
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

7.  Kinetics and renal handling of cefonicid.

Authors:  D Pitkin; J Dubb; P Actor; F Alexander; S Ehrlich; R Familiar; R Stote
Journal:  Clin Pharmacol Ther       Date:  1981-11       Impact factor: 6.875

  7 in total
  1 in total

1.  Pharmacokinetics of imipenem-cilastatin in patients with renal insufficiency undergoing continuous ambulatory peritoneal dialysis.

Authors:  P Somani; E H Freimer; M L Gross; J T Higgins
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.